These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 32630799)

  • 1. FIGO 2018 Staging for Cervical Cancer: Influence on Stage Distribution and Outcomes in the 3D-Image-Guided Brachytherapy Era.
    Tomizawa K; Kaminuma T; Murata K; Noda SE; Irie D; Kumazawa T; Oike T; Ohno T
    Cancers (Basel); 2020 Jul; 12(7):. PubMed ID: 32630799
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic Performance of the 2018 International Federation of Gynecology and Obstetrics Cervical Cancer Staging Guidelines.
    Wright JD; Matsuo K; Huang Y; Tergas AI; Hou JY; Khoury-Collado F; St Clair CM; Ananth CV; Neugut AI; Hershman DL
    Obstet Gynecol; 2019 Jul; 134(1):49-57. PubMed ID: 31188324
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Magnetic resonance imaging-based validation of the 2018 FIGO staging system in patients treated with definitive radiotherapy for locally advanced cervix cancer.
    Kim J; Cho Y; Kim N; Chung SY; Kim JW; Lee IJ; Kim YB
    Gynecol Oncol; 2021 Mar; 160(3):735-741. PubMed ID: 33358037
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improved survival of patients with cervical cancer treated with image-guided brachytherapy compared with conventional brachytherapy.
    Rijkmans EC; Nout RA; Rutten IH; Ketelaars M; Neelis KJ; Laman MS; Coen VL; Gaarenstroom KN; Kroep JR; Creutzberg CL
    Gynecol Oncol; 2014 Nov; 135(2):231-8. PubMed ID: 25172763
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A retrospective study of locally advanced cervical cancer cases treated with CT-based 3D-IGBT compared with 2D-IGBT.
    Kinoshita T; Takahashi S; Anada M; Nishide T; Kanenishi K; Kawada A; Shibata T
    Jpn J Radiol; 2023 Oct; 41(10):1164-1172. PubMed ID: 37140821
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stage Migration in Cervical Cancer Using the FIGO 2018 Staging System: A Retrospective Survival Analysis Using a Single-Institution Patient Cohort.
    Vengaloor Thomas T; Reddy KK; Gandhi S; Nittala MR; Abraham A; Robinson W; Ridgway M; Packianathan S; Vijayakumar S
    Cureus; 2021 Nov; 13(11):e19289. PubMed ID: 34877225
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of Parametrial Response by Growth Pattern in Patients With International Federation of Gynecology and Obstetrics Stage IIB and IIIB Cervical Cancer: Analysis of Patients From a Prospective, Multicenter Trial (EMBRACE).
    Yoshida K; Jastaniyah N; Sturdza A; Lindegaard J; Segedin B; Mahantshetty U; Rai B; Jürgenliemk-Schulz I; Haie-Meder C; Sasaki R; Pötter R
    Int J Radiat Oncol Biol Phys; 2015 Nov; 93(4):788-96. PubMed ID: 26530747
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overall survival in patients with FIGO stage IVA cervical cancer.
    Schiff JP; Mintz R; Cohen AC; Huang Y; Thaker P; Massad LS; Powell M; Mutch D; Schwarz JK; Markovina ST; Grigsby PW
    Gynecol Oncol; 2022 Aug; 166(2):292-299. PubMed ID: 35691754
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical outcomes following conventional external beam radiotherapy boost in Japanese patients with cervical cancer who are ineligible for intracavitary brachytherapy.
    Ito K; Shimizuguchi T; Karasawa K
    Jpn J Clin Oncol; 2019 Mar; 49(3):270-275. PubMed ID: 30576504
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The promise of image-guided brachytherapy of better clinical outcomes in treatment of cervical cancer: Does it deliver? An Indian scenario.
    Tiwari R; Narayanan GS; Jayakumar V; Narayanan S; Vishwanathan B; Mandal SK; Babu S; Ramya V; George D
    Gynecol Oncol; 2018 Sep; 150(3):420-425. PubMed ID: 30017538
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High dose-rate brachytherapy for elderly patients with uterine cervical cancer.
    Chen SW; Liang JA; Yang SN; Lin FJ
    Jpn J Clin Oncol; 2003 May; 33(5):221-8. PubMed ID: 12865465
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Validation of Revised FIGO Staging Classification for Cancer of the Ovary, Fallopian Tube, and Peritoneum Based on a Single Histological Type.
    Toptas T; Pestereli E; Erol O; Bozkurt S; Erdogan G; Simsek T
    Int J Gynecol Cancer; 2016 Jul; 26(6):1012-9. PubMed ID: 27206284
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Image guided brachytherapy in locally advanced cervical cancer: Improved pelvic control and survival in RetroEMBRACE, a multicenter cohort study.
    Sturdza A; Pötter R; Fokdal LU; Haie-Meder C; Tan LT; Mazeron R; Petric P; Šegedin B; Jurgenliemk-Schulz IM; Nomden C; Gillham C; McArdle O; Van Limbergen E; Janssen H; Hoskin P; Lowe G; Tharavichitkul E; Villafranca E; Mahantshetty U; Georg P; Kirchheiner K; Kirisits C; Tanderup K; Lindegaard JC
    Radiother Oncol; 2016 Sep; 120(3):428-433. PubMed ID: 27134181
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Computed Tomography-Planned High-Dose-Rate Brachytherapy for Treating Uterine Cervical Cancer.
    Zolciak-Siwinska A; Gruszczynska E; Bijok M; Jonska-Gmyrek J; Dabkowski M; Staniaszek J; Michalski W; Kowalczyk A; Milanowska K
    Int J Radiat Oncol Biol Phys; 2016 Sep; 96(1):87-92. PubMed ID: 27375169
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictors of distant relapse in patients with FIGO stage IIB-IVA cervical cancer treated with definitive radiotherapy.
    Okazawa-Sakai M; Mabuchi S; Isohashi F; Kawashima A; Yokoi E; Ogawa K; Kimura T
    J Obstet Gynaecol Res; 2017 Nov; 43(11):1743-1750. PubMed ID: 28816403
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intensity Modulated Radiation Therapy and Image-Guided Adapted Brachytherapy for Cervix Cancer.
    Lin AJ; Kidd E; Dehdashti F; Siegel BA; Mutic S; Thaker PH; Massad LS; Powell MA; Mutch DG; Markovina S; Schwarz J; Grigsby PW
    Int J Radiat Oncol Biol Phys; 2019 Apr; 103(5):1088-1097. PubMed ID: 30445171
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cervical cancer outcome prediction to high-dose rate brachytherapy using quantitative magnetic resonance imaging analysis of tumor response to external beam radiotherapy.
    Minkoff D; Gill BS; Kang J; Beriwal S
    Radiother Oncol; 2015 Apr; 115(1):78-83. PubMed ID: 25805517
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical outcomes of definitive chemoradiation followed by intracavitary pulsed-dose rate image-guided adaptive brachytherapy in locally advanced cervical cancer.
    Castelnau-Marchand P; Chargari C; Maroun P; Dumas I; Del Campo ER; Cao K; Petit C; Martinetti F; Tafo-Guemnie A; Lefkopoulos D; Morice P; Haie-Meder C; Mazeron R
    Gynecol Oncol; 2015 Nov; 139(2):288-94. PubMed ID: 26364808
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An Asian multi-national, multi-institutional, retrospective study on image-guided brachytherapy in cervical adenocarcinoma and adenosquamous carcinoma.
    Okonogi N; Murakami N; Ando K; Murata M; Murata K; Aoshika T; Kato S; Saito AI; Kim JY; Yoshioka Y; Sekii S; Tsujino K; Lowanichkiattikul C; Pattaranutaporn P; Kaneyasu Y; Nakagawa T; Watanabe M; Uno T; Umezawa R; Jingu K; Kanemoto A; Wakatsuki M; Shirai K; Igaki H; Ohno T; Itami J
    J Contemp Brachytherapy; 2022 Aug; 14(4):311-320. PubMed ID: 36199951
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic value of the 2018 FIGO staging system for cervical cancer patients with surgical risk factors.
    Yan DD; Tang Q; Chen JH; Tu YQ; Lv XJ
    Cancer Manag Res; 2019; 11():5473-5480. PubMed ID: 31354353
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.